Copper histidine inhibited Ctr1-mediated cellular uptake of oxaliplatin in vitro without altering oxaliplatin accumulation of platinum or neurotoxicity in DRG tissues in vivo. Copper histidine is administered orally for the treatment of Menkes disease.
Molecular Weight:
217.69
Purity:
>99.99%
CAS Number:
[77280-83-2]
Formula:
C6H8CuN3O2
Target:
Others
T67981
* VAT and and shipping costs not included. Errors and price changes excepted